Cell BioEngines, Inc.

About Cell BioEngines, Inc.

Cell BioEngines, Inc., founded in December 2022, is a clinical-stage biotech company dedicated to developing allogeneic 'off-the-shelf' stem cell therapies as drugs for treating human diseases. Their mission is to create a universal stem cell foundation platform to generate any desired human cell state on demand and at scale, to repair or replace damaged tissue, focusing on democratizing cell-based therapies for all patients.

Products & Services

Universal Stem Cell Platform:A patent-protected technology derived from donor human umbilical cord blood or tissue to generate rare, potent clinical-grade cells for therapeutics, primarily in oncology and regenerative medicine.

Cell-based Therapeutic Product Candidates:A pipeline of 'off-the-shelf' allogeneic cell therapies targeting multiple diseases, aimed at transforming medicine and healthcare.

Specialties

Allogeneic 'Off-the-Shelf' Stem Cell Therapies Oncology Regenerative Medicine Stem Cell Expansion, Differentiation, and De-differentiation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 2000000 MR: - FA: 2 million FAN: 2000000	D: 2024-07-20 FD: 2024-07-20	3 investors

Seed Latest

2024-07-20

$2.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Ajay Vishwakarma

CEO

A

Alexey Bersenev

Chief Technology Officer (CTO)

N

Nicole Uribe

Chief of Staff

M

Mark Joubert

Chief Legal Officer

J

Jay Campbell

Chief Financial Advisor

N

Nina Bhardwaj

Director of Immunotherapy

View 12 more team members with Pro

Unlock Full Team Directory

Recent News